Skip to content
#federated learning Open access

Rapport stratégique : Ir@C60 en médecine régénérative et longévité

Sep 2026 · Zenodo (CERN European Organization for Nuclear Research)

Abstract

Résumé FRCe document, produit avec l’assistance de ChatGPT 5.2 Thinking et Gemini 3 Raisonnement, est publié sous licence Apache 2.0. Il constitue une publication défensive (antériorité) et entre dans l’état de la technique au sens des législations applicables (EPC Art. 54(2); French IPC Art. L 611-11; cf. 35 U.S.C. §102(a)). Il divulgue, de manière “enabling”, un portefeuille d’innovations autour de l’endofullérène Ir@C60 : synthèse (arc DC/arc pulsé, ablation laser, confinement magnétique, mélanges de gaz), purification haut débit (HPLC parallèle, SFC→HPLC, CCC/CPC, pré-enrichissement par gradient, membranes), QA/QC (TEM/EDX, UV-Vis-NIR, ICP-MS Ir libre, intégrité de cage), formulations (IV liposomes, micelles, lyophilisats, oral huile/nanoémulsion, patchs/microneedles/implants), imagerie CT (phantoms, DECT/spectral, reconstruction IA), capteurs redox, sécurité EHS, et plateformes data (FHIR, fédéré). Abstract ENThis document, produced with the assistance of ChatGPT 5.2 Thinking and Gemini 3 Raisonnement, is released under the Apache 2.0 licence. It is a voluntary defensive publication (prior art) entering the prior art upon release under (art. L 611-11 CPI / art. 54(2) CBE), and more broadly under the applicable patent statutes (including 35 U.S.C. §102(a)). It discloses enabling, reproducible innovations centered on the Ir@C60 endohedral metallofullerene: synthesis routes (DC/pulsed arc, laser ablation, magnetic plasma shaping, inert-gas recipes), high-throughput purification (parallel HPLC, SFC-to-HPLC, CCC/CPC, density-gradient enrichment, membrane polishing), QA/QC and safety (TEM/EDX proof, UV-Vis-NIR fingerprints, free-iridium ICP-MS, cage integrity stress tests), formulations and delivery (IV PEGylated liposomes, polymeric micelles, lyophilized injectables, oral oils/nanoemulsions, transdermal patches/microneedles/implants), quantitative CT imaging (phantoms, dual-energy/spectral workflows, AI reconstruction), bioelectronic redox sensing, EHS engineering, and interoperable/federated data platforms. Timestamp: 2026-01-01T15:34:03ZSHA-256: 7195cb0a534c9b3234d9022a624dfc7998d7dc6e9e98a2dfed968b1fe5337615 Liste des innovations & classification (IPC ; CPC)1. Optimized Ir@C60 arc reactor — IPC C01B 32/00 ; CPC C01B 32/1682. Laser-ablation Ir seeding — IPC C01B 32/00 ; CPC C01B 32/1683. Auto-feed traveling anode — IPC H05B 7/00 ; CPC H05B 7/1484. Closed-loop helium recycling — IPC F17C 1/00 ; CPC F17C 1/105. Centrifuge pre-enrichment pre-HPLC — IPC B01D 21/00 ; CPC B01D 21/0086. Parallel multi-column HPLC rack — IPC B01D 15/08 ; CPC B01D 15/0837. ML chromatogram peak classifier — IPC G06F 18/20 ; CPC G06F 18/232138. Inline MS yield closed-loop — IPC G01N 27/62 ; CPC G01N 27/6229. Ir@C60 reference QC kit — IPC G01N 30/02 ; CPC G01N 30/7210. Free-iridium ICP-MS release test — IPC G01N 21/78 ; CPC G01N 21/78211. IV PEGylated liposome Ir@C60 — IPC A61K 9/127 ; CPC A61K 9/12712. Oral MCT oil Ir@C60 — IPC A61K 9/48 ; CPC A61K 9/480813. Synergistic antioxidant co-formulation — IPC A61K 31/202 ; CPC A61K 31/20214. Ir@C60 hydrogel wound dressing — IPC A61L 15/44 ; CPC A61L 15/44715. Anti-inflammatory implant coating — IPC A61L 27/06 ; CPC A61L 27/0616. 3D printed regenerative scaffold — IPC A61L 27/38 ; CPC A61L 27/3817. Ir@C60 bioelectronic redox probe — IPC G01N 27/327 ; CPC G01N 27/327618. Ir@C60 CT contrast agent — IPC A61K 49/04 ; CPC A61K 49/04319. Low-dose CT AI reconstruction — IPC G06T 5/50 ; CPC G06T 5/50120. Programmed radioprotection dosing — IPC A61P 39/06 ; CPC A61P 39/0621. Wearable ROS closed-loop dosing — IPC A61B 5/00 ; CPC G16H 40/6322. Cloud LIMS + eCRF platform — IPC G16H 10/60 ; CPC G16H 10/6023. Federated long-term safety learning — IPC G06N 20/00 ; CPC G06F 21/6224. Standard nano-endo toxicology package — IPC A61B 5/145 ; CPC G01N 33/48725. Workshop nanoparticle air monitor — IPC G01N 21/25 ; CPC G01N 21/25126. Oxygen-barrier capsule packaging — IPC B65D 81/32 ; CPC B65D 81/3227. Clean iridium provenance ledger — IPC G06Q 10/08 ; CPC G06Q 10/08328. Hydrophilization for renal clearance — IPC A61K 31/722 ; CPC A61K 31/72229. Exosome delivery of Ir@C60 — IPC A61K 47/69 ; CPC A61K 47/6930. GMP microfluidic formulation chip — IPC B01L 3/00 ; CPC B01L 3/50231. Standardized TEM Z-contrast proof — IPC G01N 23/00 ; CPC G01N 23/20332. UV-Vis-NIR Ir@C60 fingerprint — IPC G01N 21/35 ; CPC G01N 21/350433. Recycled “green” solvent skid — IPC B01D 3/00 ; CPC B01D 3/1434. Ir recovery from insoluble residues — IPC C22B 3/04 ; CPC C22B 11/0035. CO interlocked arc safety module — IPC G08B 21/00 ; CPC G08B 21/1836. Helium leak mapping by mass-spec — IPC G01M 3/00 ; CPC G01M 3/2637. Post-HPLC selective crystallization — IPC B01D 9/00 ; CPC B01D 9/0238. CT phantom calibration for Ir@C60 — IPC A61B 6/03 ; CPC A61B 6/0339. Adaptive CT contrast-to-dose control — IPC A61B 6/00 ; CPC A61B 6/0340. Liposome cold-chain traceability — IPC B65D 81/18 ; CPC B65D 81/1841. Micro-dose administration dispenser — IPC A61J 7/00 ; CPC A61J 7/0242. Longevity ePRO guided workflow — IPC G16H 20/70 ; CPC G16H 20/7043. Mitochondrial biomarker assay panel — IPC C12Q 1/00 ; CPC C12Q 1/68644. Bioaccumulation stopping-rule protocol — IPC A61B 5/145 ; CPC G16H 40/6745. Cleavable prodrug clearance design — IPC A61K 31/722 ; CPC A61K 31/72246. Endo-selective HPLC column method — IPC B01D 15/08 ; CPC B01D 15/08347. Standard soot extraction pre-analytics — IPC B01D 11/04 ; CPC B01D 11/0448. Vacuum drying anti-aggregation — IPC B01D 1/00 ; CPC B01D 1/0049. Neural microelectrode Ir@C60 coating — IPC A61N 1/05 ; CPC A61N 1/0550. Lipophilic transdermal matrix patch — IPC A61K 9/70 ; CPC A61K 9/700751. Salivary ROS point-of-care strip — IPC G01N 33/487 ; CPC G01N 33/48752. Cage integrity accelerated stress test — IPC G01N 33/50 ; CPC G01N 33/5053. Traceable GMP micro-batch workflow — IPC G06Q 10/06 ; CPC G06Q 10/063954. Parasitic metal nanoparticle detector — IPC G01N 33/487 ; CPC G01N 33/48755. Personalized Ir@C60 PK/PD model — IPC G16H 50/20 ; CPC G16H 50/2056. Federated post-market surveillance — IPC G16H 10/60 ; CPC G06F 21/6257. Photo-stable microencapsulation — IPC A61K 9/51 ; CPC A61K 9/510758. Dermal exposure dosimeter patch — IPC G01N 21/25 ; CPC G01N 21/25159. FHIR profile for nano-drugs — IPC G16H 10/60 ; CPC G16H 10/6060. Yield-to-market techno-econ model — IPC G06Q 50/00 ; CPC G06Q 50/26361. Pulsed-arc anti-dissociation recipe — IPC C01B 32/00 ; CPC C01B 32/16862. Magnetic plasma confinement coils — IPC H05H 1/24 ; CPC H05H 1/2463. Optimized He/Ne gas mixture — IPC C01B 32/00 ; CPC C01B 32/16864. Multi-zone cold soot collector — IPC B01D 46/00 ; CPC B01D 46/3065. Inline plasma OES PAT control — IPC G01N 21/63 ; CPC G01N 21/63766. Raman/FTIR extraction QC gate — IPC G01N 21/65 ; CPC G01N 21/65867. Hybrid SFC-to-HPLC purification — IPC B01D 15/08 ; CPC B01D 15/08368. Countercurrent chromatography for endo — IPC B01D 15/08 ; CPC B01D 15/08369. Membrane filtration colloid polishing — IPC B01D 61/00 ; CPC B01D 61/1470. Organic-solvent electrophoretic separation — IPC G01N 27/447 ; CPC G01N 27/447771. Inline DLS release for liposomes — IPC G01N 21/53 ; CPC G01N 21/53572. Nanomaterial endotoxin SOP — IPC G01N 33/569 ; CPC G01N 33/56973. Non-degrading sterilization selection — IPC A61L 2/00 ; CPC A61L 2/2674. Lyophilized reconstitutable IV form — IPC A61K 9/19 ; CPC A61K 9/190475. Stable oral nanoemulsion — IPC A61K 9/107 ; CPC A61K 9/107576. Polymeric micelles Ir@C60 — IPC A61K 9/51 ; CPC A61K 9/511577. Microneedle transdermal delivery — IPC A61K 9/70 ; CPC A61K 9/708478. Implantable microdose pump — IPC A61M 5/142 ; CPC A61M 5/1424479. Minimal mitochondrial targeting addend — IPC A61K 31/722 ; CPC A61K 31/72280. Isolated mitochondria ROS assay — IPC C12Q 1/00 ; CPC C12Q 1/68681. High-content ROS imaging assay — IPC G01N 33/487 ; CPC G01N 33/48782. Dual-energy CT quantification protocol — IPC A61B 6/03 ; CPC A61B 6/0383. Spectral CT k-edge workflow — IPC A61B 6/03 ; CPC A61B 6/0384. Ex vivo tissue XRF mapping — IPC G01N 23/00 ; CPC G01N 23/20785. Washout scheduling optimization — IPC A61P 39/06 ; CPC A61P 39/0686. Antioxidant interaction guardrails — IPC A61K 31/202 ; CPC A61K 31/20287. QR + spectral anti-counterfeit — IPC G06Q 20/40 ; CPC G06Q 20/4088. Immutable QC data watermarking — IPC G06F 21/64 ; CPC G06F 21/64289. Endo-fullerene data ontology — IPC G16H 10/60 ; CPC G16H 10/6090. Secure edge inference on wearable — IPC G06F 21/52 ; CPC G06F 21/5691. QC calibration-as-a-service platform — IPC G06Q 10/06 ; CPC G06Q 10/063992. Energy-normalized yield KPI — IPC G06Q 50/06 ; CPC G06Q 50/26393. Arc-process digital twin — IPC G06F 30/20 ; CPC G06F 30/2094. Isotopic mass-balance PK tracing — IPC G01N 33/50 ; CPC G01N 33/5095. Safe D2C nutraceutical logistics — IPC G06Q 10/08 ; CPC G06Q 10/08396. Nano solvent waste treatment SOP — IPC B09B 3/00 ; CPC B09B 3/6097. Nanodrug hemocompatibility panel — IPC G01N 33/53 ; CPC G01N 33/5398. “Ir-free” leaching proof standard — IPC G01N 21/78 ; CPC G01N 21/78299. Product photoprotection protocol — IPC B65D 81/26 ; CPC B65D 81/26100. Emerging-market frugal deployment — IPC G06Q 50/06 ; CPC G06Q 50/263 KeywordsIr@C60, endohedral metallofullerene, iridium encapsulation, arc-discharge synthesis, laser ablation, HPLC purification, density-gradient centrifugation, mitochondrial ROS scavenging, liposome formulation, nutraceutical longevity, CT contrast agent, AI imaging reconstruction, bioelectronic redox sensor, closed-loop dosing, federated safety analytics, nanotoxicology, GMP microfluidics, supply-chain provenance, packaging shelf-life

View source

Similar papers

#machine learning Review Open access Oct 2014

Software development in startup companies: A systematic mapping study

The results indicate that software engineering work practices are chosen opportunistically, adapted and configured to provide value under the constrains imposed by the startup context.

Nicolò Paternoster, Carmine Giardino, M. Unterkalmsteiner et al. · 394 citations · ⚡54
#machine learning Review Open access Jun 2014

Why Early-Stage Software Startups Fail: A Behavioral Framework

This state-of-practice investigation was performed using a literature review followed by a multiple-case study approach and presents how inconsistency between managerial strategies and execution can lead to failure by means of a behavioral framework.

Carmine Giardino, Xiaofeng Wang, P. Abrahamsson · 175 citations · ⚡19
#machine learning Review Open access Oct 2016

“Failures” to be celebrated: an analysis of major pivots of software startups

This study conducts a case survey study based on the secondary data of the major pivots happened in 49 software startups, and demonstrates that customer need pivot is the most common among all pivot types.

Sohaib Shahid Bajwa, Xiaofeng Wang, Anh Nguyen-Duc et al. · 127 citations · ⚡15
#machine learning Review Open access May 2016

Key Challenges in Software Startups Across Life Cycle Stages

It is found that what perceived as biggest challenges by software startups do vary across different life cycle stages, even though its significance decreases when the learning focuses of the startups move from problem to solution and their products mature.

Xiaofeng Wang, Henry Edison, Sohaib Shahid Bajwa et al. · 62 citations · ⚡6

Related blog posts

Microsoft Research Blog Sep 30, 2026

Forecasting space weather risks on power grids

Extreme space-weather events can damage power systems on Earth and degrade GPS accuracy and satellite operations. A new machine learning system can predict where damage is likely to occur 30-60 minutes before a storm arrives. The post Forecasting space weather risks on power grids appeared first on Microsoft Research.

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.